PT Kalbe Farma Tbk (PTKFF)
0.0926
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
PT Kalbe Farma Profit Margin (Quarterly): 11.45% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 11.45% |
December 31, 2023 | 8.90% |
September 30, 2023 | 7.26% |
June 30, 2023 | 9.21% |
March 31, 2023 | 10.87% |
December 31, 2022 | 11.57% |
September 30, 2022 | 11.61% |
June 30, 2022 | 11.69% |
March 31, 2022 | 11.90% |
December 31, 2021 | 12.51% |
September 30, 2021 | 11.75% |
June 30, 2021 | 12.29% |
March 31, 2021 | 11.91% |
December 31, 2020 | 11.73% |
September 30, 2020 | 11.65% |
June 30, 2020 | 12.36% |
March 31, 2020 | 11.55% |
December 31, 2019 | 10.18% |
September 30, 2019 | 11.64% |
June 30, 2019 | 11.41% |
March 31, 2019 | 11.09% |
December 31, 2018 | 12.10% |
September 30, 2018 | 11.11% |
June 30, 2018 | 11.67% |
March 31, 2018 | 11.75% |
Date | Value |
---|---|
December 31, 2017 | 12.26% |
September 30, 2017 | 11.21% |
June 30, 2017 | 12.15% |
March 31, 2017 | 12.01% |
December 31, 2016 | 11.95% |
September 30, 2016 | 11.54% |
June 30, 2016 | 11.65% |
March 31, 2016 | 12.38% |
December 31, 2015 | 10.61% |
September 30, 2015 | 9.89% |
June 30, 2015 | 11.95% |
March 31, 2015 | 12.45% |
December 31, 2014 | 12.57% |
September 30, 2014 | 11.28% |
June 30, 2014 | 11.59% |
March 31, 2014 | 12.13% |
December 31, 2013 | 12.13% |
September 30, 2013 | 11.05% |
June 30, 2013 | 12.16% |
March 31, 2013 | 12.72% |
December 31, 2012 | 12.46% |
September 30, 2012 | 12.62% |
June 30, 2012 | 12.47% |
March 31, 2012 | 13.42% |
December 31, 2011 | 12.96% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
7.26%
Minimum
Sep 2023
12.51%
Maximum
Dec 2021
11.17%
Average
11.63%
Median
Profit Margin (Quarterly) Benchmarks
Taihe Group Inc | -- |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -14.54K% |
IGC Pharma Inc | -2.74K% |
NovaBay Pharmaceuticals Inc | -122.2% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 12.55% |
Return on Assets | 10.33% |
Return on Invested Capital | 12.03% |
Gross Profit Margin (Quarterly) | 39.71% |
Operating Margin (Quarterly) | 14.62% |
Return on Net Operating Assets | 11.57% |